InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2023-01-04 00:00:00 ET · period of report 2022-12-31 · accession 0001209191-23-001437 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-01-04 2022-12-31 WGS Ryan Jason Executive COB, Dir M - OptEx — +247.5K 263.4K +1,563% —
D 2023-01-04 2022-12-31 WGS Ryan Jason Executive COB, Dir S - Sale+OE $0.26 -73.7K 189.6K -28% -$19.2K
D 2023-01-04 2022-12-31 WGS Ryan Jason Executive COB, Dir M - OptEx $0.00 -247.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-12-31 M A 247,525 — 263,358 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Common Class A Common Stock 2022-12-31 S D 73,732 $0.26 189,626 D — —
3 Derivative Restricted Stock Unit 2022-12-31 M D 247,525 $0.00 0 D — · — to — 247,525 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 100% of the RSUs vested as of December 31, 2022, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances.